Esperion Therapeutics (0IIM.LSE) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.21
-0.15
-0.08
-0.02

Details

Expected EPS
-0.078329
Actual EPS
-0.16
Surprise EPS
-0.08
Surprise Percent
+104.27%

Description

Esperion Therapeutics (0IIM.LSE) has reported earnings of -0.16 per share for Q4 2025.

0 Comments

Share your thoughts